BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2691808)

  • 21. Comparison of triazolam and methyprylon as a hypnotic in insomniacs.
    Linet OI; Rudzik AD
    Psychopharmacol Commun; 1975; 1(5):473-80. PubMed ID: 7002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preference studies of triazolam with standard hypnotics in out-patients with insomnia.
    Fabre LF; McLendon DM; Harris RT
    J Int Med Res; 1976; 4(4):247-54. PubMed ID: 16801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.
    Ankier SI; Goa KL
    Drugs; 1988 Jan; 35(1):42-62. PubMed ID: 2894293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled clinical evaluation of 2 hypnotic triazole benzodiazepines, estazolam and triazolam, used the night before surgical interventions].
    Mauro C; Sperlongano P
    Minerva Med; 1987 Sep; 78(18):1381-4. PubMed ID: 2889169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term quazepam treatment of insomnia in geriatric patients.
    Caldwell JR
    Pharmatherapeutica; 1982; 3(4):278-82. PubMed ID: 6128741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of triazolam and chloral hydrate in geriatric insomniacs.
    Piccione P; Zorick F; Lutz T; Grissom T; Kramer M; Roth T
    J Int Med Res; 1980; 8(5):361-7. PubMed ID: 6106611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.
    Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby JA; Kales JD
    Clin Pharmacol Ther; 1986 Mar; 39(3):345-52. PubMed ID: 2868823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs].
    Stepanski E; Zorick F; Kaffeman M; Sicklesteel J; Roth T
    Nouv Presse Med; 1982 Oct; 11(40):2987-90. PubMed ID: 6128721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rebound insomnia and elimination half-life: assessment of individual subject response.
    Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
    J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic use of triazolam: the effects on the sleep patterns of insomniacs.
    Pegram V; Hyde P; Linton P
    J Int Med Res; 1980; 8(3):224-31. PubMed ID: 6104615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs.
    Elie R; Frenay M; Le Morvan P; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():39-46. PubMed ID: 2201729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study.
    Tietz EI; Roth T; Zorick FJ; Piccione P; Kramer M
    Arzneimittelforschung; 1981; 31(11):1963-6. PubMed ID: 6119098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term treatment with quazepam of insomnia in geriatric patients.
    Martinez HT; Serna CT
    Clin Ther; 1982; 5(2):174-8. PubMed ID: 6130842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of short-term treatment with 30 mg of quazepam in insomniac outpatients.
    O'Hair DE; Winsauer HJ
    Clin Ther; 1981; 4(4):291-301. PubMed ID: 7037183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia.
    Clark BG; Jue SG; Dawson GW; Ward A
    Drugs; 1986 Jun; 31(6):500-16. PubMed ID: 2874007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triazolam (Halcion) versus flunitrazepam (Rohypnol) against midwinter insomnia in Northern Norway.
    Lingjaerde O; Bratlid T
    Acta Psychiatr Scand; 1981 Sep; 64(3):260-9. PubMed ID: 6119872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
    Bliwise DL; Seidel WF; Cohen SA; Bliwise NG; Dement WC
    J Clin Psychiatry; 1988 Sep; 49(9):349-55. PubMed ID: 3047100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients.
    Lomen P; Linet OI
    J Int Med Res; 1976; 4(1):55-8. PubMed ID: 16792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind crossover comparison of triazolam and lorazepam in the posthypnotic state.
    Cohn JB
    J Clin Psychiatry; 1984 Mar; 45(3):104-7. PubMed ID: 6142034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
    Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
    N Engl J Med; 1987 Sep; 317(12):722-8. PubMed ID: 3306380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.